Literature DB >> 12469

Drug therapy of tardive dyskinesia.

R M Kobayashi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 12469     DOI： 10.1056/NEJM197702032960506

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

1.  The effect of drug holidays in an animal model of tardive dyskinesia.

Authors:  J Bannet; R H Belmaker; R P Ebstein
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

2.  The effect of age and thioridazine on the in vitro binding of fluphenazine to normal human serum.

Authors:  F J Rowell; S M Hui; A F Fairbairn; D Eccleston
Journal:  Br J Clin Pharmacol       Date:  1980-04       Impact factor: 4.335

Review 3.  Management of the schizophrenic patient.

Authors:  M V Seeman
Journal:  Can Med Assoc J       Date:  1979-05-05       Impact factor: 8.262

4.  Dopaminergic supersensitivity: influence of dopamine agonists, cholinergics, anticholinergics, and drugs used for the treatment of tardive dyskinesia.

Authors:  A V Christensen; I M Nielsen
Journal:  Psychopharmacology (Berl)       Date:  1979-04-11       Impact factor: 4.530

5.  Total and free serum haloperidol levels in schizophrenic patients and the effect of age thioridazine and fatty acid on haloperidol-serum protein binding in vitro.

Authors:  F J Rowell; S M Hui; A F Fairbairn; D Eccleston
Journal:  Br J Clin Pharmacol       Date:  1981-04       Impact factor: 4.335

6.  A study of antipsychotic drug use in nursing homes: epidemiologic evidence suggesting misuse.

Authors:  W A Ray; C F Federspiel; W Schaffner
Journal:  Am J Public Health       Date:  1980-05       Impact factor: 9.308

7.  Metoclopramide in tardive dyskinesia.

Authors:  T J Hemanani; P G Dashputra; R N Sarda
Journal:  Indian J Psychiatry       Date:  1983-04       Impact factor: 1.759
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.